1. Home
  2. NL vs ALLO Comparison

NL vs ALLO Comparison

Compare NL & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NL
  • ALLO
  • Stock Information
  • Founded
  • NL 1891
  • ALLO 2017
  • Country
  • NL United States
  • ALLO United States
  • Employees
  • NL N/A
  • ALLO N/A
  • Industry
  • NL Major Chemicals
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NL Industrials
  • ALLO Health Care
  • Exchange
  • NL Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • NL 362.9M
  • ALLO 371.8M
  • IPO Year
  • NL N/A
  • ALLO 2018
  • Fundamental
  • Price
  • NL $8.05
  • ALLO $1.17
  • Analyst Decision
  • NL Sell
  • ALLO Strong Buy
  • Analyst Count
  • NL 1
  • ALLO 10
  • Target Price
  • NL $6.00
  • ALLO $9.66
  • AVG Volume (30 Days)
  • NL 26.3K
  • ALLO 3.0M
  • Earning Date
  • NL 05-07-2025
  • ALLO 05-13-2025
  • Dividend Yield
  • NL 4.46%
  • ALLO N/A
  • EPS Growth
  • NL 441.25
  • ALLO N/A
  • EPS
  • NL 1.25
  • ALLO N/A
  • Revenue
  • NL $148,242,000.00
  • ALLO $22,000.00
  • Revenue This Year
  • NL $15.75
  • ALLO N/A
  • Revenue Next Year
  • NL $2.44
  • ALLO $9.07
  • P/E Ratio
  • NL $6.47
  • ALLO N/A
  • Revenue Growth
  • NL N/A
  • ALLO N/A
  • 52 Week Low
  • NL $5.20
  • ALLO $1.09
  • 52 Week High
  • NL $9.42
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • NL 48.23
  • ALLO 38.89
  • Support Level
  • NL $8.22
  • ALLO $1.09
  • Resistance Level
  • NL $9.27
  • ALLO $1.78
  • Average True Range (ATR)
  • NL 0.40
  • ALLO 0.14
  • MACD
  • NL -0.01
  • ALLO -0.03
  • Stochastic Oscillator
  • NL 28.24
  • ALLO 27.46

About NL NL Industries Inc.

NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: